PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 20507639-1 2010 BACKGROUND: Our previous study showed that, in basal cell carcinoma cells, arecoline reduces levels of the tumor cell survival factor interleukin-6 (IL-6), increases levels of tumor suppressor factor p53, and elicits cell cycle arrest, followed by apoptosis. Arecoline 75-84 interleukin 6 Homo sapiens 134-147 25529330-0 2015 Arecoline increases basic fibroblast growth factor but reduces expression of IL-1, IL-6, G-CSF and GM-CSF in human umbilical vein endothelium. Arecoline 0-9 interleukin 6 Homo sapiens 83-87 22108589-0 2012 Arecoline decreases interleukin-6 production and induces apoptosis and cell cycle arrest in human basal cell carcinoma cells. Arecoline 0-9 interleukin 6 Homo sapiens 20-33 22108589-1 2012 Arecoline, the most abundant areca alkaloid, has been reported to decrease interleukin-6 (IL-6) levels in epithelial cancer cells. Arecoline 0-9 interleukin 6 Homo sapiens 75-88 22108589-1 2012 Arecoline, the most abundant areca alkaloid, has been reported to decrease interleukin-6 (IL-6) levels in epithelial cancer cells. Arecoline 0-9 interleukin 6 Homo sapiens 90-94 22108589-2 2012 Since IL-6 overexpression contributes to the tumorigenic potency of basal cell carcinoma (BCC), this study was designed to investigate whether arecoline altered IL-6 expression and its downstream regulation of apoptosis and the cell cycle in cultured BCC-1/KMC cells. Arecoline 143-152 interleukin 6 Homo sapiens 161-165 22108589-4 2012 After 24h exposure, arecoline inhibited BCC-1/KMC cell growth and decreased IL-6 production in terms of mRNA expression and protein secretion, but had no effect on HaCaT cells. Arecoline 20-29 interleukin 6 Homo sapiens 76-80 22108589-8 2012 This study demonstrates that arecoline has potential for preventing BCC tumorigenesis by reducing levels of the tumor cell survival factor IL-6, increasing levels of the tumor suppressor factor p53, and eliciting cell cycle arrest, followed by apoptosis. Arecoline 29-38 interleukin 6 Homo sapiens 139-143 20507639-1 2010 BACKGROUND: Our previous study showed that, in basal cell carcinoma cells, arecoline reduces levels of the tumor cell survival factor interleukin-6 (IL-6), increases levels of tumor suppressor factor p53, and elicits cell cycle arrest, followed by apoptosis. Arecoline 75-84 interleukin 6 Homo sapiens 149-153 15533212-0 2004 Regulation of interleukin-6 expression by arecoline in human buccal mucosal fibroblasts is related to intracellular glutathione levels. Arecoline 42-51 interleukin 6 Homo sapiens 14-27 15533212-5 2004 The effects of arecoline, the major areca nut alkaloid, on IL-6 expression in normal human buccal mucosa fibroblasts (BMFs) were measured in vitro. Arecoline 15-24 interleukin 6 Homo sapiens 59-63 15533212-7 2004 To determine whether glutathione (GSH) levels were important in the induction of IL-6 by arecoline, we pretreated cells with 2-oxothiazolidine-4-carboxylic acid (OTZ) to boost GSH levels or with buthionine sulfoximine (BSO) to deplete GSH. Arecoline 89-98 interleukin 6 Homo sapiens 81-85 15533212-9 2004 The exposure of quiescent BMF to arecoline resulted in the elevation of IL-6 mRNA expression in a dose-dependent manner (P < 0.05). Arecoline 33-42 interleukin 6 Homo sapiens 72-76 15533212-10 2004 IL-6 gene regulated by arecoline correlated with intracellular GSH levels in BMF. Arecoline 23-32 interleukin 6 Homo sapiens 0-4 15533212-11 2004 Arecoline at a concentration of 129 muM induced about 2.7-fold IL-6 mRNA levels over the 6-h incubation period. Arecoline 0-9 interleukin 6 Homo sapiens 63-67 15533212-13 2004 In addition, OTZ was found to marginally reduce the arecoline-induced IL-6 expression by about 1.7-fold (P < 0.05). Arecoline 52-61 interleukin 6 Homo sapiens 70-74 15533212-14 2004 CONCLUSIONS: Taken together, these results suggest that IL-6 expression is significantly upregulated in OSF fibroblasts in areca quid chewers and arecoline may be responsible for the enhanced IL-6 expression. Arecoline 146-155 interleukin 6 Homo sapiens 56-60 15533212-14 2004 CONCLUSIONS: Taken together, these results suggest that IL-6 expression is significantly upregulated in OSF fibroblasts in areca quid chewers and arecoline may be responsible for the enhanced IL-6 expression. Arecoline 146-155 interleukin 6 Homo sapiens 192-196 15533212-15 2004 In addition, the regulation of IL-6 expression induced by arecoline is critically dependent on the intracellular GSH concentrations. Arecoline 58-67 interleukin 6 Homo sapiens 31-35 7490793-1 1995 This study aimed to assess the possibility of a direct effect of betel-nut alkaloids arecoline and arecaidine on cell proliferation and interleukin-6 (IL-6) production by cultured fibroblasts from human normal gingiva, buccal mucosa and oral submucous fibrosis (OSF) buccal mucosa in vitro. Arecoline 85-94 interleukin 6 Homo sapiens 136-149 7490793-9 1995 However, two of six individuals" normal buccal mucosa fibroblasts significantly released less IL-6, and some cases of OSF and healthy gingiva exhibited slightly higher levels of IL-6 when cells were exposed to arecoline or arecaidine in cultures. Arecoline 210-219 interleukin 6 Homo sapiens 178-182 7490793-10 1995 Such findings suggests that arecoline and arecaidine can enhance cell proliferation and affect fibroblasts to synthesize IL-6. Arecoline 28-37 interleukin 6 Homo sapiens 121-125 31610043-11 2020 RESULTS: We have found that the stimulation of arecoline on FBs increased interleukin-2, interleukin-6, and interleukin-21 (IL-2, IL-6, and IL-21) while decreased transforming growth cytokine-beta (TGF-beta). Arecoline 47-56 interleukin 6 Homo sapiens 89-102 31610043-11 2020 RESULTS: We have found that the stimulation of arecoline on FBs increased interleukin-2, interleukin-6, and interleukin-21 (IL-2, IL-6, and IL-21) while decreased transforming growth cytokine-beta (TGF-beta). Arecoline 47-56 interleukin 6 Homo sapiens 130-134